Literature DB >> 2862389

Indication for therapy in multiple myeloma: should it be stage or stability?

D E Joshua, A Wearne, H Kronenberg.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2862389     DOI： 10.1016/s0140-6736(85)91518-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma.

Authors:  J Bladé; J San Miguel; A Alcalá; J Maldonado; J García-Conde; M J Moro; M A Sanz Sanz; C Alonso; A Zubizarreta; C Besses
Journal:  Blut       Date:  1990-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.